An Update on the Pathogenesis of Fascioliasis: What Do We Know?

References

• Caravedo MA, Cabada MM. Human Fascioliasis: current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control. Res Rep Trop Med. 2020;11:149–158.
   PubMed Web of Science ®Google Scholar
• May K, Bohlsen E, Konig S, Strube C. Fasciola hepatica seroprevalence in Northern German dairy herds and associations with milk production parameters and milk ketone bodies. Vet Parasitol. 2020;277:109016.
   PubMed Web of Science ®Google Scholar
• Mehmood K, Zhang H, Sabir AJ, et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Microb Pathog. 2017;109:253–262.
   PubMed Web of Science ®Google Scholar
• Donnelly S, Flynn RJ, Mulcahy G, O’Neill SM Chapter Immunological interaction between Fasciola and its host. In Fascioliasis II. 2022. Available from: http://hdl.handle.net/10453/166688. Accessed January 31, 2024.
   Google Scholar
• Lalor R, Cwiklinski K, Calvani NED, et al. Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola gigantica that cause the zoonosis Fasciolosis. Virulence. 2021;12(1):2839–2867.
   PubMed Web of Science ®Google Scholar
• Chang Wong MR, Pinto Elera JO, Guzman Rojas P, Terashima Iwashita A, Samalvides cuba F. Caracterizacion clinica y epidemiologica de la infeccion por Fasciola hepatica entre los años 2003-2010 en el Hospital Nacional Cayetano Heredia, Lima, Peru. [Demographic and clinical aspects of Fasciola hepatica between 2013-2010 in National Hospital Cayetano Heredia, Lima, Peru] Spanish. Rev Gastroenterol Peru. 2016;36(1):23–28.
   PubMedGoogle Scholar
• Machicado C, Machicado JD, Maco V, Terashima A, Marcos LA. Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: a Systematic Review. PLoS Negl Trop Dis. 2016;10(9):e0004962.
   PubMed Web of Science ®Google Scholar
• Cabada MM, Goodrich MR, Graham B, et al. Prevalence of intestinal helminths, anemia, and malnutrition in Paucartambo, Peru. Rev Panam Salud Publica. 2015;37(2):69–75.
   PubMed Web of Science ®Google Scholar
• Vázquez AA, Alda P, Lounnas M, et al. Lymnaeid snails hosts of Fasciola hepatica and Fasciola gigantica (Trematoda: digenea): a worldwide review. CABI Reviews. 2018;1–15.
   Google Scholar
• Mas-Coma S, Bargues MD, Valero MA. Human fascioliasis infection sources, their diversity, incidence factors, analytical methods and prevention measures. Parasitology. 2018;145(13):1665–1699.
   PubMed Web of Science ®Google Scholar
• Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol. 2004;113(1):30–37.
   PubMed Web of Science ®Google Scholar
• Cwiklinski K, Jewhurst H, McVeigh P, et al. Infection by the Helminth Parasite Fasciola hepatica Requires Rapid Regulation of Metabolic, Virulence, and Invasive Factors to Adjust to Its Mammalian Host. Mol Cell Proteomics. 2018;17(4):792–809.
   PubMed Web of Science ®Google Scholar
• Andreyanov ON, Postevoy AN, Sidor EA. The effect of ambient temperature on biological properties and energy metabolism of Fasciola hepatica metacercariae. Vet Parasitol. 2021;299:109576.
   PubMed Web of Science ®Google Scholar
• Dow C, Ross JG, Todd JR. The histopathology of Fasciola hepatica infections in sheep. Parasitology. 1968;58(1):129–135.
   PubMedGoogle Scholar
• Van Milligen FJ, Cornelissen JB, Hendriks IM, Gaasenbeek CP, Bokhout BA. Protection of Fasciola hepatica in the gut mucosa of immune rats is associated with infiltrates of eosinophils, IgG1 and IgG2a antibodies around the parasites. Parasite Immunol. 1998;20(6):285–292.
   PubMed Web of Science ®Google Scholar
• Zafra R, Perez-Ecija RA, Buffoni L, et al. Early hepatic and peritoneal changes and immune response in goats vaccinated with a recombinant glutathione transferase sigma class and challenged with Fasciola hepatica. Res Vet Sci. 2013;94(3):602–609.
   PubMed Web of Science ®Google Scholar
• van Milligen FJ, Cornelissen JB, Gaasenbeek CP, Bokhout BA. A novel ex vivo rat infection model to study protective immunity against Fasciola hepatica at the gut level. J Immunol Methods. 1998;213(2):183–190.
   PubMed Web of Science ®Google Scholar
• Wicki P, Schwalbach B, Charbon JL, et al. Réactions cellulaires intestinales du bovin après infection par Fasciola hepatica [Intestinal cellular reaction of cattle after infection by Fasciola hepatica]. Schweiz Arch Tierheilkd. 1991;133(9):429–437.
   PubMed Web of Science ®Google Scholar
• Ruiz-Campillo MT, Molina Hernandez V, Escamilla A, et al. Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica. Sci Rep. 2017;7:2782.
   PubMed Web of Science ®Google Scholar
• Robinson MW, Hutchinson AT, Dalton JP, Donnelly S. Peroxiredoxin: a central player in immune modulation. Parasite Immunol. 2010;32(5):305–313.
   PubMed Web of Science ®Google Scholar
• Di Maggio LS, Tirloni L, Pinto AF, et al. Across intra-mammalian stages of the liver fluke Fasciola hepatica: a proteomic study. Sci Rep. 2016;6:32796.
   PubMed Web of Science ®Google Scholar
• Figueroa-Santiago O, Espino AM. Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages. Infect Immun. 2014;82(12):5005–5012.
   PubMed Web of Science ®Google Scholar
• Ryan S, Shiels J, Taggart CC, Dalton JP, Weldon S. Fasciola hepatica-Derived Molecules as Regulators of the Host Immune Response. Front Immunol. 2020;11:2182.
   PubMed Web of Science ®Google Scholar
• Robinson MW, Alvarado R, To J, et al. A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. FASEB J. 2012;26(11):4614–4627.
   PubMed Web of Science ®Google Scholar
• Martinez-Sernandez V, Mezo M, Gonzalez-Warleta M, et al. The MF6p/FhHDM-1 major antigen secreted by the trematode parasite Fasciola hepatica is a heme-binding protein. J Biol Chem. 2014;289(3):1441–1456.
   PubMed Web of Science ®Google Scholar
• O’Neill S, Donnelly S. Mechanisms of Immune Modulation by Fasciola hepatica: the Impact of Innate Immune Cells on the Developing Adaptive Immune Response. In: Jirillo E, Magrone T, Miragliotta G, editors. In Immune Response to Parasitic Infections: Immunity to Helminths and Novel Therapeutic. Approaches. Bentham Books; 2014.
   Google Scholar
• Flynn RJ, Mulcahy G, Elsheikha HM. Coordinating innate and adaptive immunity in Fasciola hepatica infection: implications for control. Vet Parasitol. 2010;169(3–4):235–240.
   PubMed Web of Science ®Google Scholar
• Ravida A, Cwiklinski K, Aldridge AM, et al. Fasciola hepatica Surface Tegument: glycoproteins at the Interface of Parasite and Host. Mol Cell Proteomics. 2016;15(10):3139–3153.
   PubMed Web of Science ®Google Scholar
• Adams PN, Aldridge A, Vukman KV, Donnelly S, O’Neill SM. Fasciola hepatica tegumental antigens indirectly induce an M2 macrophage-like phenotype in vivo. Parasite Immunol. 2014;36(10):531–539.
   PubMed Web of Science ®Google Scholar
• Vukman KV, Adams PN, Metz M, Maurer M, O’Neill SM. Fasciola hepatica tegumental coat impairs mast cells’ ability to drive Th1 immune responses. J Immunol. 2013;190(6):2873–2879.
   PubMed Web of Science ®Google Scholar
• Cameron TC, Cooke I, Faou P, et al. A novel ex vivo immunoproteomic approach characterizing Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep. Int J Parasitol. 2017;47(9):555–567.
   PubMed Web of Science ®Google Scholar
• Morales A, Espino AM. Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol. 2012;19(11):1870–1878.
   PubMedGoogle Scholar
• Trelis M, Sanchez-Lopez CM, Sanchez-Palencia LF, Ramirez-Toledo V, Marcilla A, Bernal D. Proteomic Analysis of Extracellular Vesicles from Fasciola hepatica Hatching Eggs and Juveniles in Culture. Front Cell Infect Microbiol. 2022;12:903602.
   PubMed Web of Science ®Google Scholar
• Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol. 2009;183(3):1577–1586.
   PubMed Web of Science ®Google Scholar
• Flynn RJ, Mulcahy G. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-gamma production during experimental Fasciola hepatica infection. Int J Parasitol. 2008;38(14):1673–1680.
   PubMed Web of Science ®Google Scholar
• Donnelly S, O’Neill SM, Sekiya M, Mulcahy G, Dalton JP. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun. 2005;73(1):166–173.
   PubMed Web of Science ®Google Scholar
• Donnelly S, Stack CM, O’Neill SM, Sayed AA, Williams DL, Dalton JP. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J. 2008;22(11):4022–4032.
   PubMed Web of Science ®Google Scholar
• Naranjo-Lucena A, Correia CN, Molina-Hernandez V, et al. Transcriptomic Analysis of Ovine Hepatic Lymph Node Following Fasciola hepatica Infection - Inhibition of NK Cell and IgE-Mediated Signaling. Front Immunol. 2021;12:687579.
   PubMed Web of Science ®Google Scholar
• Rodriguez E, Noya V, Cervi L, et al. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells. PLoS Negl Trop Dis. 2015;9(12):e0004234.
   PubMed Web of Science ®Google Scholar
• Dowling DJ, Hamilton CM, Donnelly S, et al. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun. 2010;78(2):793–801.
   PubMed Web of Science ®Google Scholar
• De Marco Verissimo C, Jewhurst HL, Tikhonova IG, et al. Fasciola hepatica serine protease inhibitor family (serpins): purposely crafted for regulating host proteases. PLoS Negl Trop Dis. 2020;14(8):e0008510.
   PubMed Web of Science ®Google Scholar
• Donnelly S, Stack CM, O’Neill SM, Sayed AA, Williams DL, Dalton JP. Helminth 2-Cys peroxiredoxin drives responses through a mechanism involving alternatively activated macrophages. FASEB J. 2008;22(11):4022.
   PubMed Web of Science ®Google Scholar
• Aron-Said C, Montes M, White AC, Cabada MM. Plasma cytokines during acute human fascioliasis. Parasitol Res. 2021;120(8):2965–2968.
   PubMed Web of Science ®Google Scholar
• Frigerio S, da Costa V, Costa M, et al. Eosinophils Control Liver Damage by Modulating Immune Responses Against Fasciola hepatica. Front Immunol. 2020;11:579801.
   PubMed Web of Science ®Google Scholar
• Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT. Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol Immunopathol. 2007;117(3–4):197–208.
   PubMed Web of Science ®Google Scholar
• Carmona C, Dowd AJ, Smith AM, Dalton JP. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol Biochem Parasitol. 1993;62(1):9–17.
   PubMed Web of Science ®Google Scholar
• Bramhall M, Zaph C. Mastering gut permeability: new roles for old friends. Eur J Immunol. 2017;47(2):236–239. doi:10.1002/eji.201646842
   PubMed Web of Science ®Google Scholar
• Robinson MW, Dalton JP, O’Neill SM, Donnelly SM. Chapter 27: mechanisms of Immune Modulation by Fasciola hepatica: importance for Vaccine Development and for Novel Immunotherapeutics. In: Cr C, editor. Parasitic Helminths: Targets, Screens, Drugs and Vaccines. Wiley Online Library; 2012.
   Google Scholar
• Cruz AA, Lima F, Sarinho E, et al. Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection. Clin Exp Allergy. 2007;37(2):197–207.
   PubMed Web of Science ®Google Scholar
• Silva SML, Vindimian M, Wattre P, Capron A. Etude des anticorps IgE dans la distomatose humaine a Fasciola hepatica. [IgE antibodies in human Fasciola hepatica distomiasis] French. Pathol Biol. 1985;33(7):746–750.
   PubMedGoogle Scholar
• Kita H, Kaneko M, Bartemes KR, et al. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol. 1999;162(11):6901–6911.
   PubMed Web of Science ®Google Scholar
• Hamilton CM, Dowling DJ, Loscher CE, Morphew RM, Brophy PM, O’Neill SM. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun. 2009;77(6):2488–2498.
   PubMed Web of Science ®Google Scholar
• Morrison CA, Colin T, Sexton JL, et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine. 1996;14(17–18):1603–1612.
   PubMed Web of Science ®Google Scholar
• Golden O, Flynn RJ, Read C, et al. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine. 2010;28(34):5551–5557.
   PubMed Web of Science ®Google Scholar
• Zafra R, Buffoni L, Perez-Caballero R, et al. Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep. Vet Res. 2021;52(1):13.
   PubMed Web of Science ®Google Scholar
• Maggio L, Tirloni L, Uhl M, et al. Serpins in Fasciola hepatica: insights into host-parasite interactions. Int J Parasitol. 2020;50(12):931–943.
   PubMed Web of Science ®Google Scholar
• Smith AM, Dowd AJ, Heffernan M, Robertson CD, Dalton JP. Fasciola hepatica: a secreted cathepsin L-like proteinase cleaves host immunoglobulin. Int J Parasitol. 1993;23(8):977–983.
   PubMed Web of Science ®Google Scholar
• De Marco Verissimo C, Jewhurst HL, Dobo J, Gal P, Dalton JP, Cwiklinski K. Fasciola hepatica is refractory to complement killing by preventing attachment of mannose binding lectin (MBL) and inhibiting MBL-associated serine proteases (MASPs) with serpins. PLoS Pathog. 2022;18(1):e1010226.
   PubMed Web of Science ®Google Scholar
• Guasconi L, Serradell MC, Masih DT, Chiapello LS. Immunomodulatory Effect of Fasciola hepatica Excretory–Secretory Products on Macrophages. In: Fasciola Hepatica: Methods and Protocols. Springer; 2020.
   Google Scholar
• White MPJ, McManus CM, Maizels RM. Regulatory T-cells in helminth infection: induction, function and therapeutic potential. Immunology. 2020;160(3):248–260.
   PubMed Web of Science ®Google Scholar
• Lund ME, O’Brien BA, Hutchinson AT, et al. Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One. 2014;9(1):e86289.
   PubMed Web of Science ®Google Scholar
• Costa M, da Costa V, Lores P, et al. Macrophage Gal/GalNAc lectin 2 (MGL2)(+) peritoneal antigen presenting cells during Fasciola hepatica infection are essential for regulatory T cell induction. Sci Rep. 2022;12(1):17661.
   PubMed Web of Science ®Google Scholar
• Costa M, da Costa V, Frigerio S, et al. Heme-Oxygenase-1 Attenuates Oxidative Functions of Antigen Presenting Cells and Promotes Regulatory T Cell Differentiation during Fasciola hepatica Infection. Antioxidants. 2021;10(12):1322.
   Web of Science ®Google Scholar
• Gironènes N, Valero AM, García-Bodelón MA, et al. Immune Suppression in Advanced Chronic Fascioliasis: an Experimental Study in a Rat Model. J Infectious Dis. 2007;195(10):1504–1512.
   PubMed Web of Science ®Google Scholar
• Richter J, Freise S, Mull R, Millan JC. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Trop Med Int Health. 1999;4(11):774–781.
   PubMed Web of Science ®Google Scholar
• Oyarzun-Ruiz P, Alvelo C, Vera F, Moroni M. Histopathological findings of Fasciola hepatica infection in non-native European hare (Lepus europaeus) in Southern Chile. Rev Bras Parasitol Vet. 2019;28(1):145–150.
   PubMed Web of Science ®Google Scholar
• Matsuda K, Kogame S, Niki H, Saito M, Ishiguro Y, Sano Y. Gross and histological lesions in the livers of sika deer with particular emphasis on fascioliasis. J Vet Med Sci. 2020;82(2):125–134.
   PubMed Web of Science ®Google Scholar
• Capucchio MT, Catalano D, Di Marco V, et al. Natural trematode infestation in feral Nebrodi Black pigs: pathological investigations. Vet Parasitol. 2009;159(1):37–42.
   PubMed Web of Science ®Google Scholar
• Mpisana Z, Jaja IF, Byaruhanga C, Marufu MC. Body condition scores, fluke intensity, liver pathology, and carcass quality of different dairy cattle genotypes infected with Fasciola species at high throughput abattoirs in South Africa. Parasitol Res. 2022;121(6):1671–1682.
   PubMed Web of Science ®Google Scholar
• Winaya IBO, Oka IBM, Adnyana IBW, Sudipa PH. Fibrosis and Collagen-I Accumulation in Bali Cattle Liver Tissue Infected with Fasciola gigantica. Inter J Vet Sc. 2023;12(2):224–229.
   Google Scholar
• Phiri AM, Phiri IK, Sikasunge CS, Chembensofu M, Monrad J. Comparative fluke burden and pathology in condemned and non-condemned cattle livers from selected abattoirs in Zambia. Onderstepoort J Vet Res. 2006;73(4):275–281.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mei X, Liang Y, et al. Newly excysted juveniles (NEJs) of Fasciola gigantica induce mice liver fibrosis and M2 macrophage-like phenotype in vivo. Microb Pathog. 2020;139:103909.
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk L, Laszczynska M, Masiuk M, Grabowska M, Skrzydlewska E. Immunoexpression of intermediate filaments and morphological changes in the liver and bile duct of rats infected with Fasciola hepatica. Biotech Histochem. 2015;90(7):477–485.
   PubMed Web of Science ®Google Scholar
• Marcos LA, Terashima A, Yi P, et al. Mechanisms of liver fibrosis associated with experimental Fasciola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell activation. J Parasitol. 2011;97(1):82–87.
   PubMed Web of Science ®Google Scholar
• Alvarez Rojas CA, Ansell BR, Hall RS, et al. Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver. Parasit Vectors. 2015;8:124.
   PubMed Web of Science ®Google Scholar
• Almendras-Jaramillo M, Rivera-Medina J, Seijas-Mogrovejo J, Almendras-Jaramillo K. Fascioliasis Hepatica En niños: manifestaciones clinicas poco frecuentes. [Hepatic fascioliasis in children: uncommon clinical manifestations] Spanish. Arq Gastroenterol. 1997;34(4):241–247.
   PubMedGoogle Scholar
• Marcos LA, Maco V, Castillo M, Terashima A, Zerpa R, Gotuzzo E. Reporte de casos de Fasciolosis humana en el Instituto Especializado de Salud del Nino, Lima, Peru (1988-2003). [Report of cases of human fascioliasis in the Specialized Children’s Health Institute, Lima, Peru (1988’-2003)] Spanish. Rev Gastroenterol Peru. 2005;25(2):198–205.
   PubMedGoogle Scholar
• Sanchez-Sosa S, Rojas-Ortega S, Reed-San Roman G, Torres-Santana MA. Fasciolosis hepatobiliar masiva. [Massive hepatobiliary fascioliasis] Spanish. Rev Gastroenterol Mex. 2000;65(4):179–183.
   PubMedGoogle Scholar
• Bestas R, Yalcin K, Cicek M. Cholestasis caused by Fasciola gigantica. Turkiye Parazitol Derg. 2014;38(3):201–204.
   PubMedGoogle Scholar
• Hosamirudsari H JRY. Fasciola hepatica an Unusual Cause of Chronic Cholecystitis. Int J Infect. 2015;2(2):e23108.
   Google Scholar
• Guzman Calderon E, Vera Calderon A, Diaz Rios R, Arcana Lopez R, Alva Alva E. Fasciola hepatica in the common bile duct: spyglass visualization and endoscopic extraction. Rev Esp Enferm Dig. 2018;110(10):671–673.
   PubMed Web of Science ®Google Scholar
• Gulsen MT, Savas MC, Koruk M, Kadayifci A, Demirci F. Fascioliasis: a report of five cases presenting with common bile duct obstruction. Neth J Med. 2006;64(1):17–19.
   PubMed Web of Science ®Google Scholar
• Dolay K, Hasbahceci M, Hatipoglu E, Umit Malya F, Akcakaya A. Endoscopic diagnosis and treatment of biliary obstruction due to acute cholangitis and acute pancreatitis secondary to Fasciola hepatica infection. Ulus Travma Acil Cerrahi Derg. 2018;24(1):71–73.
   PubMed Web of Science ®Google Scholar
• Ha JS, Choi HJ, Moon JH, et al. Endoscopic Extraction of Biliary Fascioliasis Diagnosed Using Intraductal Ultrasonography in a Patient with Acute Cholangitis. Clin Endosc. 2015;48(6):579–582.
   PubMedGoogle Scholar
• Veerappan A, Siegel JH, Podany J, Prudente R, Gelb A. Fasciola hepatica pancreatitis: endoscopic extraction of live parasites. Gastrointest Endosc. 1991;37(4):473–475.
   PubMed Web of Science ®Google Scholar
• Dzib Calan EA, Larracilla Salazar I, Morales Perez JI. A giant liver abscess due to Fasciola hepatica infection. Rev Esp Enferm Dig. 2019;111(10):815–816.
   PubMed Web of Science ®Google Scholar
• Losada H, Hirsch M, Guzman P, Fonseca F, Hofmann E, Alanis M. Fascioliasis simulating an intrahepatic cholangiocarcinoma-Case report with imaging and pathology correlation. Hepatobiliary Surg Nutr. 2015;4(1).
   PubMed Web of Science ®Google Scholar
• Wang H, Itoh S, Matsumoto Y, et al. Surgically resected hepatic mass caused by fascioliasis. Clin J Gastroenterol. 2021;14(2):662–667.
   PubMed Web of Science ®Google Scholar
• Yen TJ, Hsiao CH, Hu RH, Liu KL, Chen CH. Education and imaging: hepatobiliary and pancreatic: chronic hepatic abscess associated with fascioliasis. J Gastroenterol Hepatol. 2011;26(3):611.
   PubMed Web of Science ®Google Scholar
• Sripa B, Kanla P, Sinawat P, Haswell-Elkins MR. Opisthorchiasis-associated biliary stones: light and scanning electron microscopic study. World J Gastroenterol. 2004;10(22):3318–3321.
   PubMed Web of Science ®Google Scholar
• Pfeifer CM, Bourm KS, Brandt MR, Ali K. Liver fluke-induced choledocholithiasis with biliary ductal obstruction. Radiol Case Rep. 2019;14(12):1483–1486.
   PubMedGoogle Scholar
• Lefryekh R, Bensaad A, Bensardi F, et al. Hepatic fascioliasis presenting with bile duct obstruction: a case report. Pan Afr Med J. 2017;28:44.
   PubMedGoogle Scholar
• Brahmbhatt NN, Kumar B, Thakre BJ, Bilwal AK. Haemato-biochemical characterization of fasciolosis in Gir cattle and Jaffrabadi buffaloes. J Parasit Dis. 2021;45(3):683–688.
   PubMedGoogle Scholar
• Javaregowda AK, Rani KB. Chronic bovine fasciolosis associated cholangiolithiasis: a case report. J Parasit Dis. 2017;41(1):90–92.
   PubMedGoogle Scholar
• Valero MA, Santana M, Morales M, Hernandez JL, Mas-Coma S. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J Infect Dis. 2003;188(5):787–793.
   PubMed Web of Science ®Google Scholar
• Valero MA, Varea MT, Marin R. Fasciola hepatica: lithogenic capacity in experimentally infested rats and chemical determination of the main stone components. Parasitol Res. 2000;86(7):558–562.
   PubMed Web of Science ®Google Scholar
• Cetta F. The role of bacteria in pigment gallstone disease. Ann Surg. 1991;213(4):315–326.
   PubMed Web of Science ®Google Scholar
• Binda C, Gibiino G, Coluccio C, et al. Biliary Diseases from the Microbiome Perspective: how Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms. 2022;10(2):312.
   PubMed Web of Science ®Google Scholar
• Stewart L, Grifiss JM, Jarvis GA, Way LW. Biliary bacterial factors determine the path of gallstone formation. Am J Surg. 2006;192(5):598–603.
   PubMed Web of Science ®Google Scholar
• Dan WY, Yang YS, Peng LH, Sun G, Wang ZK. Gastrointestinal microbiome and cholelithiasis: current status and perspectives. World J Gastroenterol. 2023;29(10):1589–1601.
   PubMed Web of Science ®Google Scholar
• Ramirez AL, Herrera G, Munoz M, et al. Describing the intestinal microbiota of Holstein Fasciola-positive and -negative cattle from a hyperendemic area of fascioliasis in central Colombia. PLoS Negl Trop Dis. 2021;15(8):45.
   Web of Science ®Google Scholar
• Humans IWGotEoCRt. Biological agents. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B).
   Google Scholar
• Liau MYQ, Toh EQ, Shelat VG. Opisthorchis viverrini-Current Understanding of the Neglected Hepatobiliary Parasite. Pathogens. 2023;12(6):56.
   Web of Science ®Google Scholar
• Salazar M, Ituarte C, Abriata MG, Santoro F, Arroyo G. Gallbladder cancer in South America: epidemiology and prevention. Chin Clin Oncol. 2019;8(4):32.
   PubMed Web of Science ®Google Scholar
• Machicado C, Marcos LA, Zimic M. Hypothetical granulin-like molecule from Fasciola hepatica identified by bioinformatics analysis. Springerplus. 2016;5(1):773.
   PubMedGoogle Scholar
• Vale N, Gouveia MJ, Gartner F, Brindley PJ. Oxysterols of helminth parasites and pathogenesis of foodborne hepatic trematodiasis caused by Opisthorchis and Fasciola species. Parasitol Res. 2020;119(5):1443–1453.
   PubMed Web of Science ®Google Scholar
• Bottari NB, Mendes RE, Baldissera MD, et al. Relation between iron metabolism and antioxidants enzymes and delta-ALA-D activity in rats experimentally infected by Fasciola hepatica. Exp Parasitol. 2016;165:58–63.
   PubMed Web of Science ®Google Scholar
• Swain B, Otta S, Sahu MK, Uthansingh K. Fasciola hepatica association with gallbladder malignancy: a rare case report. Trop Parasitol. 2021;11(1):42–45.
   PubMedGoogle Scholar
• Lopez M, White AC Jr, Cabada MM. Burden of Fasciola hepatica Infection among children from Paucartambo in Cusco, Peru. Am J Trop Med Hyg. 2012;86(3):481–485.
   PubMed Web of Science ®Google Scholar
• Stuen S, Ersdal C. Fasciolosis-An Increasing Challenge in the Sheep Industry. Animals. 2022;12(12).
   Web of Science ®Google Scholar
• Wong RK, Peura DA, Mutter ML, Heit HA, Birns MT, Johnson LF. Hemobilia and liver flukes in a patient from Thailand. Gastroenterology. 1985;88(6):1958–1963.
   PubMed Web of Science ®Google Scholar
• Bahcecioglu IH, Ataseven H, Aygen E, Coskun S, Kuzu N, Ilhan F. Fasciola hepatica case with hemobilia. Acta Medica. 2007;50(2):155–156.
   Google Scholar
• Acuna-Soto R, Braun-Roth G. Bleeding ulcer in the common bile duct due to Fasciola hepatica. Am J Gastroenterol. 1987;82(6):560–562.
   PubMed Web of Science ®Google Scholar
• Leon M, Alave J, Alvarado R, Gotuzzo E, Terashima A, Seas C. A 52-year-old woman with a subcapsular liver hematoma. Clin Infect Dis. 2011;52(9):1137, 1195–6.
   PubMed Web of Science ®Google Scholar
• Loja Oropeza D, Alvizuri Escobedo J, Vilca Vasquez M, Aviles Gonzaga R, Sanchez Mercado M. Hematoma hepatico subcapsular por Fasciola. [Hepatic subcapsular hematoma caused by fascioliasis] Spanish. Rev Gastroenterol Peru. 2003;23(2):142–148.
   PubMedGoogle Scholar
• Montembault S, Serfaty L, Poirot JL, Wendum D, Penna C, Poupon R. Ascite hemorragique revelant une infection massive a Fasciola hepatica. [Hemorrhagic ascites disclosing massive Fasciola hepatica infection] French. Gastroenterol Clin Biol. 1997;21(10):785–788.
   PubMedGoogle Scholar
• Sukhdeo MV, Sangster NC, Mettrick DF. Permanent feeding sites of adult Fasciola hepatica in rabbits? Int J Parasitol. 1988;18(4):509–512.
   PubMed Web of Science ®Google Scholar
• Valero MA, Girones N, Garcia-Bodelon MA, et al. Anaemia in advanced chronic fasciolosis. Acta Trop. 2008;108(1):35–43.
   PubMed Web of Science ®Google Scholar
• Lotfollahzadeh S, Mohri M, Bahadori Sh R, Dezfouly MR, Tajik P. The relationship between normocytic, hypochromic anaemia and iron concentration together with hepatic enzyme activities in cattle infected with Fasciola hepatica. J Helminthol. 2008;82(1):85–88.
   PubMed Web of Science ®Google Scholar
• Shrimali RG, Patel MD, Patel RM. Comparative efficacy of anthelmintics and their effects on hemato-biochemical changes in fasciolosis of goats of South Gujarat. Vet World. 2016;9(5):524–529.
   PubMedGoogle Scholar
• El-Shazly AM, El-Nahas HA, Abdel-Mageed AA, et al. Human fascioliasis and anaemia in Dakahlia Governorate, Egypt. J Egypt Soc Parasitol. 2005;35(2):421–432.
   PubMedGoogle Scholar
• Valero MA, Perez-Crespo I, Chillon-Marinas C, et al. Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia. PLoS One. 2017;12(3).
   Web of Science ®Google Scholar
• Rashid M, Zahra N, Chudhary A, et al. Cost-benefit ratio of anthelmintic treatment and its comparative efficacy in commercial dairy farms. Front Vet Sci. 2022;9:1047497.
   PubMed Web of Science ®Google Scholar
• Karahocagil MK, Akdeniz H, Sunnetcioglu M, et al. A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature. Acta Trop. 2011;118(3):177–183.
   PubMed Web of Science ®Google Scholar